SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that the company will present corporate updates at two investor conferences next week. Dr. J. Joseph Kim, president and CEO, was also invited to participate on a panel, “Predicting a Frontrunner in the Race Against Pandemic Flu,” at BIO Investor Forum.
